Perrigo Company PRGO Infant Formula — Restructuring charges and other termination benefits

Of the amount recorded during three months ended June 27, 2026, our Self Care and Specialty Care segments reversed charges in the amounts of $0.8 million and $3.8 million, respectively, due primarily to adjustments to employee separation costs related to the Operational Enhancement Program. Of the amount recorded during the six months ended June 27, 2026, our Self Care and Specialty Care segments incurred charges in the amounts of $35.8 million and $8.4 million, respectively, due primarily to employee separation costs related to the Operational Enhancement Program. Of the amount recorded during the three and six months ended June 27, 2026, $14.8 million and $22.5 million, respectively, related to our Infant Formula segment, due primarily to Nutrition Network Optimization. Charges totaling $5.0 million and $18.5 million during the three and six months ended June 27, 2026, respectively, primarily for separation costs associated with the Operational Enhancement Program were corporate costs not allocated to a reporting segment.